Premium
Ulipristal acetate: new oral treatment for uterine fibroids
Author(s) -
McVeigh Enda
Publication year - 2012
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.981
Subject(s) - ulipristal acetate , uterine fibroids , medicine , gynecology , adverse effect , research methodology , family planning , population , environmental health
Ulipristal acetate is the first progesterone receptor modulator licensed for the preoperative treatment of uterine fibroids. Our New products review presents the clinical data relating to its efficacy and adverse events and considers its place in medical management of uterine fibroids.